Company Filing History:
Years Active: 2004-2018
Title: Hiroko Yoshida: Innovator in Therapeutic Antibodies
Introduction
Hiroko Yoshida is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 4 patents to her name, her work focuses on innovative solutions for treating cancer and autoimmune diseases.
Latest Patents
One of her latest patents involves anti-DR5 antibodies, polynucleotides, and methods. This invention relates to an antibody that exhibits a therapeutic effect on cancer, autoimmune diseases, or inflammatory diseases. The antibody demonstrates cytotoxic activity against cells expressing death domain-containing receptors through apoptosis. The objective of this invention is to provide a pharmaceutical with a therapeutic effect on cancer. Notably, this novel anti-DR5 antibody is capable of inducing apoptosis in cells and has more potent cytotoxic activity than currently available anti-DR5 antibodies.
Career Highlights
Hiroko Yoshida has worked with notable companies such as Sankyo Company, Limited and Daiichi Sankyo Company, Limited. Her experience in these organizations has contributed to her expertise in the field of therapeutic innovations.
Collaborations
Throughout her career, she has collaborated with esteemed colleagues, including Nobufusa Serizawa and Kimihisa Ichikawa. These partnerships have further enhanced her research and development efforts.
Conclusion
Hiroko Yoshida's contributions to the field of therapeutic antibodies highlight her innovative spirit and dedication to improving healthcare solutions. Her work continues to pave the way for advancements in cancer treatment and beyond.